Neogenomics Inc.'s Chief Medical Officer just picked up 14,492 shares

Maher Albitar, Neogenomics Inc.'s Chief Medical Officer, recently acquired 14,492 shares of the company. The buys took place at $3.51 per share, on March 28, 2014. Albitar now owns 63,492 shares of the company. Albitar operates out of Fort Myers, FL. Some additional info was provided as follows:

These stock options were granted upon the start of Mr. Albitar's service to the Company and vest ratably over each of his first four anniversaries with the Company. These warrants were issued to Mr. Albitar upon the start of his service to the Company and vest upon the acheivement of certain currently unmet milestones.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever Neogenomics Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Neogenomics Reports Record Revenues Of $20.7 Million On 40% Test Volume Growth And Expanding Gross Margins For The Second Quarter 2014 - July 17, 2014

   Auto Refresh

Feedback